|
MedChemExpress
palbociclib isethionate ![]() Palbociclib Isethionate, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/palbociclib isethionate/product/MedChemExpress Average 94 stars, based on 1 article reviews
palbociclib isethionate - by Bioz Stars,
2026-02
94/100 stars
|
Buy from Supplier |
|
Tocris
pd 0332991 isethionate ![]() Pd 0332991 Isethionate, supplied by Tocris, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/pd 0332991 isethionate/product/Tocris Average 99 stars, based on 1 article reviews
pd 0332991 isethionate - by Bioz Stars,
2026-02
99/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
palbociclib ![]() Palbociclib, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/palbociclib/product/Santa Cruz Biotechnology Average 90 stars, based on 1 article reviews
palbociclib - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Tocris
pd0332991 ![]() Pd0332991, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/pd0332991/product/Tocris Average 93 stars, based on 1 article reviews
pd0332991 - by Bioz Stars,
2026-02
93/100 stars
|
Buy from Supplier |
|
LC Laboratories
palbociclib (pd 0332991) isethionate ![]() Palbociclib (Pd 0332991) Isethionate, supplied by LC Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/palbociclib (pd 0332991) isethionate/product/LC Laboratories Average 90 stars, based on 1 article reviews
palbociclib (pd 0332991) isethionate - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: bioRxiv
Article Title: Retroelement decay by the exonuclease XRN1 is a viral mimicry dependency in cancer
doi: 10.1101/2023.03.30.531699
Figure Lengend Snippet: dsRNA induced by Palbociclib or 5-AZA-CdR produces a synthetic dependency to XRN1 in XRN1-resistant POP92 cells. (A) Dot blot for dsRNA using total RNA from indicated cell lines. Normalized amounts of total RNA were dotted on Hybond N+ membranes, visualized by methylene blue staining, and immunoblotted with J2 antibody. (B) Representative confocal microscopy images of colorectal cell lines. Nuclei were stained with DAPI (blue) and dsRNA was stained using the J2 antibody (red). (C) Representative confocal microscopy images from control and knockout of XRN1 of POP92 cells treated with PBS or 5-AZA-CdR. Nuclei were stained with DAPI (blue) and dsRNA was stained using the J2 antibody (red). (D) Survival of wild-type XRN1 (black) and XRN1 knockout (red) patient-derived CRC cells (POP92) after treatment with 5-AZA-CdR. Luminescence signal was normalized, and dose-response curves and EC50 values were calculated using a nonlinear regression curve fit. (E) Survival of wild-type XRN1 (black) and XRN1-knockout (red) POP92 cells after treatment with palbociclib. Luminescent signal was normalized, and dose-response curves and EC50 values were calculated using a nonlinear regression curve fit.
Article Snippet:
Techniques: Dot Blot, Staining, Confocal Microscopy, Control, Knock-Out, Derivative Assay
Journal: bioRxiv
Article Title: Retroelement decay by the exonuclease XRN1 is a viral mimicry dependency in cancer
doi: 10.1101/2023.03.30.531699
Figure Lengend Snippet: Proposed mechanism for XRN1 dependent viral mimicry adaptation. A) XRN1 resistant cell lines have low levels of immunogenic dsRNA and are therefore not relying on XRN1 to resist viral mimicry induced cell death. XRN1 sensitive cell lines require XRN1 to resist high levels of immunogenic dsRNA to induce viral mimicry induced cell death. Viral mimicry inducing drugs such as 5-AZA-CdR and palbociclib can generate a synthetic dependency to XRN1. B) XRN1 degrades dsRNA while ADAR1 edits A-to-I in dsRNA, these mechanisms have different effects on activation of MDA5 and PKR pathways. When ADAR1 and XRN1 are not present, both MDA5 and PKR can bind dsRNA and activate viral mimicry. If XRN1 is knocked out and only ADAR1 is present, the edited dsRNA will not activate the MDA5 pathway while the PKR pathway can still be activated. If both XRN1 and ADAR1 is present, dsRNA is both edited and degraded which hinders activation of MDA5 and PKR pathways.
Article Snippet:
Techniques: Activation Assay
Journal: Molecular cell
Article Title: Cyclin D-Cdk4,6 Drives Cell-Cycle Progression via the Retinoblastoma Protein’s C-Terminal Helix
doi: 10.1016/j.molcel.2019.03.020
Figure Lengend Snippet: KEY RESOURCES TABLE
Article Snippet:
Techniques: Purification, Produced, Virus, Recombinant, Selection, Membrane, Flow Cytometry, Expressing, Plasmid Preparation, Generated